Cetera Advisor Networks LLC Charles River Laboratories International, Inc. Transaction History

Cetera Advisor Networks LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$203.52 - $273.43 $8,954 - $12,030	44 Added 0.8%	5,577 $1.51 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $31,916 - $46,334	-194 Reduced 3.39%	5,533 $1.31 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $51,526 - $57,666	-265 Reduced 4.42%	5,727 $1.12 Million
Q2 2023 Aug 09, 2023	BUY	$183.71 - $210.25 $29,393 - $33,640	160 Added 2.74%	5,992 $1.26 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $16,310 - $22,093	-85 Reduced 1.44%	5,832 $1.18 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $1.17 Million - $1.48 Million	5,917 New	5,917 $1.29 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $43,538 - $56,159	-248 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $29,472 - $47,050	248 New	248 $43,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.